DATA FROM THE TOP TEN ENROLLING COUNTRIES CONTAINED IN THE PROGRESS (PROMOTING GLOBAL RESEARCH EXCELLENCE IN SEVERE SEPSIS) REGISTRY DEMONSTRATES VARIATIONS IN TREATMENT AND HIGH MORTALITY RATES
Konrad Reinhart(Charité - Universitätsmedizin Berlin), Jonathan Janes(Eli Lilly (United States)), Greg S. Martin(Emory University), Eliezer Silva(Universidade Estadual da Paraíba), Frank M. Brunkhorst, Mary Ann Turlo, Claudio Martín(Jena University Hospital), Samiha Sarwat(St Thomas' Hospital), Mitchell Levy(Universidade de São Paulo), Graham Ramsay(Radboud University Nijmegen), Richard Beale(St Thomas' Hospital), Jean‐Louis Vincent(Université Libre de Bruxelles)
Cited by 1
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k